Monitor for additional insider selling or news catalysts; current activity is modest and within normal range for a small-cap biotech.
KPTI drugs
KPTI drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $9.59entry
- T+1 · 9mo ago −4.80%α −3.88% · $9.13
- T+5 · 8mo ago −11.47%α −10.26% · $8.49
- T+20 · 8mo ago −44.73%α −36.80% · $5.30
- T+60 · 6mo ago −6.47%α −15.79% · $8.97
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
KPTI insiders sold a combined $164K in open-market transactions over the past week, including CEO Richard Paulson and EVP Reshma Rangwala. The sales represent a small fraction of market cap and align with recent insider activity.
Key Financial Metrics
Key Facts
- CEO Richard Paulson sold $116,311 in shares at $9.41 per share.
- EVP & Chief Medical Officer Reshma Rangwala sold $47,669 in shares at same price.
- Total open-market sales: $163,980 over 7 days.
- Sales represent approximately 0.093% of KPTI's $176M market cap.
Financial Impact
$164K in insider sales, or 0.093% of market cap
Risk Factors
- Perception of lack of confidence if selling continues ahead of key events (e.g., clinical data, FDA decisions).
- Small company size amplifies sensitivity to insider moves over time.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-KPTI-1772573421300 |
Track record
30 reports on KPTI
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +97.24% at T+60 after the Aug 13, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.0102 Now $0.0290 +184.31% settles Feb 12
- Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.0102 Now $0.0290 −184.31% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $0.0295 Now $0.0290 −1.69% settles Feb 10
- Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $0.0400 Now $0.0290 −27.50% settles Feb 5
- Nov 5, 202611d ago 8-K Bearish 8/10 Entry $0.0601 Now $0.0290 +51.75% settles Feb 3
- Nov 2, 202614d ago 8-K Bearish 10/10 Entry $0.0883 Now $0.0290 +67.16% settles Feb 1
- Nov 2, 202614d ago 8-K Bearish 7/10 Entry $0.1120 Now $0.0290 +74.11% settles Jan 29
- Oct 28, 202619d ago SC 13G/A Bearish 5/10 Entry $0.8798 Now $0.0290 +96.70% settles Jan 27
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $0.5175 Now $0.0290 +94.40% settles Jan 21
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $0.3150 Now $0.0290 −90.79% settles Jan 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers